A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer.
Pautier P, Vergote I, Joly F, Melichar B, Kutarska E, Hall G, Lisyanskaya A, Reed N, Oaknin A, Ostapenko V, Zvirbule Z, Chetaille E, Geniaux A, Shoaib M, Green JA.
Pautier P, et al. Among authors: green ja.
Int J Gynecol Cancer. 2017 Feb;27(2):258-266. doi: 10.1097/IGC.0000000000000862.
Int J Gynecol Cancer. 2017.
PMID: 27870712
Clinical Trial.